Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  American Journal of Psychiatry

• Publication date

  2002-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1176/APPI.AJP.159.5.746PMID 11986127
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional networks in motor sequence learning: Abnormal topographies in Parkinson's disease

  2001cited by this paper
• The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease

  2000cited by this paper
• Basal ganglia and cerebellar loops: motor and cognitive circuits.

  2000cited by this paper
• Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study.

  2000cited by this paper
• Reactivation of encoding-related brain activity during memory retrieval.

  2000cited by this paper
• Functional Anatomy of High-Resolution Visual Mental Imagery

  2000cited by this paper
• Reproducibility of regional metabolic covariance patterns: comparison of four populations.

  1999cited by this paper
• Clinicopathological heterogeneity and non-dopaminergic influences on behavior in Parkinson's disease.

  1999cited by this paper
• Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness.

  1999cited by this paper
• The cerebellum plays a role in conscious episodic memory retrieval

  1999cited by this paper
• Interactions of prefrontal cortex in relation to awareness in sensory learning.

  1999cited by this paper
• Cognitive functioning after pallidotomy for refractory Parkinson’s disease

  1998cited by this paper
• Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions.

  1998cited by this paper
• Increasing required neural response to expose abnormal brain function in mild versus moderate or severe Alzheimer's disease: PET study using parametric visual stimulation.

  1998cited by this paper
• Lewy body dementia--clinical, pathological and neurochemical interconnections.

  1997cited by this paper
• Spatial pattern analysis of functional brain images using partial least squares.

  1996cited by this paper
• Cognitive deficits in Parkinson’s disease

  1996cited by this paper
• Frequency of dementia in Parkinson disease.

  1996cited by this paper
• Application of the Parametric Bootstrap to Models that Incorporate a Singular Value Decomposition

  1995cited by this paper
• Clues about the functional neuroanatomy of verbal working memory: a study of resting brain glucose metabolism in Parkinson's disease

  1995cited by this paper
• Depression in Parkinson's disease: a biochemical and organic viewpoint.

  1995cited by this paper
• Depression in Parkinson's Disease

  1994cited by this paper
• Impaired simultaneous cognitive task performance in Parkinson's disease

  1994cited by this paper
• Statistical parametric maps in functional imaging: A general linear approach

  1994cited by this paper
• The Metabolic Topography of Parkinsonism

  1994cited by this paper
• Neuropsychological and Glucose Metabolic Profiles in Asymmetric Parkinson’s Disease

  1992cited by this paper
• A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease.

  1992cited by this paper
• Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients.

  1992cited by this paper
• Cognitive function and regional cerebral blood flow in Parkinson's disease.

  1992cited by this paper
• Depression and Parkinson's disease: a review.

  1992cited by this paper
• Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment.

  1992cited by this paper
• Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability.

  1991cited by this paper
• Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease

  1990cited by this paper
• Large‐scale neurocognitive networks and distributed processing for attention, language, and memory

  1990cited by this paper
• Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268

  1990cited by this paper
• Cognitive function in Parkinson's disease: from description to theory.

  1990cited by this paper
• Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

  1989cited by this paper
• 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa.

  1988cited by this paper
• The relationship of serotonin to depression in Parkinson's disease

  1988cited by this paper
• Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory.

  1988cited by this paper
• Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy

  1986cited by this paper
• Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.

  1985cited by this paper
• Apparent discrepancy between single-unit activity and [14C]deoxyglucose labeling in optic tectum of the rattlesnake.

  1983cited by this paper
• Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.

  1983cited by this paper
• Dementia in Parkinson disease: a neuropsychological analysis.

  1982cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• Parkinsonism

  1967cited by this paper
• An inventory for measuring depression.

  1961cited by this paper

• Neuroimaging Advances in Neuropsychiatric Symptoms Associated with Parkinson’s Disease

  2025cites this paper
• Cholinergic Denervation Patterns in Parkinson's Disease Associated With Cognitive Impairment Across Domains

  2025cites this paper
• Increased Inflammation and Treatment of Depression: From Resistance to Reuse, Repurposing, and Redesign.

  2023cites this paper
• Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19

  2023cites this paper
• Depression in Patients with Parkinson’s Disease: Current Understanding of its Neurobiology and Implications for Treatment

  2022cites this paper
• Inflammation as a Pathophysiologic Pathway to Anhedonia: Mechanisms and Therapeutic Implications.

  2022cites this paper
• Management of psychiatric and cognitive complications in Parkinson’s disease

  2022cites this paper
• Quantifying regional α ‐synuclein, amyloid β, and tau accumulation in lewy body dementia

  2022influential citation
• Clinical Trials In Parkinson's Disease

  2021cites this paper
• Parkinson’s Disease

  2021cites this paper
• Psychiatric Issues in Parkinson Disease

  2021cites this paper
• Impaired perception of illusory contours and cortical hypometabolism in patients with Parkinson’s disease

  2021cites this paper
• Networks Are Associated With Depression in Patients With Parkinson’s Disease: A Resting-State Imaging Study

  2021cites this paper
• Clinical Trials for Depression , Anxiety , Fatigue , and Apathy in Parkinson’s Disease

  2021cites this paper
• for , , , and in Parkinson’s

  2020cites this paper
• The Relationship Between the Striatal Dopaminergic Neuronal and Cognitive Function With Aging

  2020cites this paper
• Regional Parieto-occipital Hypoperfusion on Arterial Spin Labeling Associates with Major Depressive Disorder

  2020cites this paper
• Management of psychiatric disorders in Parkinson’s disease

  2020cites this paper
• SPECT and PET in Late-Life Depression

  2020cites this paper
• Comparison of Quantitative Electroencephalogram During Sleep in Depressed and Non-Depressed Patients with Parkinson’s Disease

  2019cites this paper
• Maladie de Parkinson et dépression

  2019cites this paper
• Network Imaging in Parkinsonian and Other Movement Disorders: Network Dysfunction and Clinical Correlates.

  2019cites this paper
• Neuropsychology of Movement Disorders and Motor Neuron Disease: Parkinson’s Disease, Progressive Supranuclear Palsy, Essential Tremor, Huntington’s Disease, and Amyotrophic Lateral Sclerosis

  2019cites this paper
• Neuroprotective Effects of Rasagiline in Parkinson's Disease: A Regional Cerebral Blood Flow Study

  2019cites this paper
• The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

  2019cites this paper
• DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson ' s disease

  2019cites this paper
• Role of Inflammation in Depression and Treatment Implications.

  2019cites this paper
• Malattia di Parkinson e depressione

  2019cites this paper
• Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease.

  2019cites this paper
• A potential mechanistic role for neuroinflammation in reward processing impairments in autism spectrum disorder.

  2019cites this paper
• Visuospatial and visuoperceptual impairment and its structural correlates as measures of cognitive decline in parkinson's disease

  2018cites this paper
• Imaging the Nonmotor Symptoms in Parkinson's Disease.

  2017cites this paper
• Imaging the Role of Inflammation in Mood and Anxiety-related Disorders

  2017cites this paper
• 4 Neuropsychological Functions and SPECT Neuroimaging in Parkinson ’ s Disease

  2017cites this paper
• Behavioral and Psychological Symptoms of Dementia

  2017cites this paper
• Aberrant Intra- and Internetwork Functional Connectivity in Depressed Parkinson’s Disease

  2017cites this paper
• Inflammation Effects on Motivation and Motor Activity: Role of Dopamine

  2017cites this paper
• Imaging the Etiology of Apathy, Anxiety, and Depression in Parkinson’s Disease: Implication for Treatment

  2017cites this paper
• The Role of Dopamine in Inflammation-Associated Depression: Mechanisms and Therapeutic Implications.

  2016cites this paper
• Brain perfusion alterations in depressed patients with Parkinson’s disease

  2016cites this paper
• Emotional manifestations of PD: Neurobiological basis

  2016cites this paper
• Impaired interhemispheric synchrony in Parkinson’s disease with depression

  2016cites this paper
• Depression, anxiety, and apathy in Parkinson's disease: insights from neuroimaging studies

  2016cites this paper
• The research domain criteria framework: The case for anterior cingulate cortex.

  2016cites this paper
• Mesolimbic dopaminergic dysfunction in Parkinson’s disease depression: evidence from a 123I-FP-CIT SPECT investigation

  2015cites this paper
• Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses

  2015cites this paper
• Association of specific frequency bands of functional MRI signal oscillations with motor symptoms and depression in Parkinson’s disease

  2015cites this paper
• Vers l'imagerie in vivo de l'alpha-synucléine.

  2015cites this paper
• Dopaminergic Modulation of Medial Prefrontal Cortex Deactivation in Parkinson Depression

  2015cites this paper
• Predicting dementia in Parkinson disease by combining neurophysiologic and cognitive markers

  2014influential citation
• Characterization of disease‐related covariance topographies with SSMPCA toolbox: Effects of spatial normalization and PET scanners

  2014cites this paper
• Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson’s disease

  2014cites this paper
• Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficits

  2014cites this paper
• olecular imaging of neuropsychiatric symptoms in Alzheimer ’ s and arkinson ’ s disease

  2014cites this paper
• Depression and impulse control disorders in Parkinson's disease: two sides of the same coin?

  2014influential citation
• The cerebellum in Parkinson’s disease

  2013cites this paper
• Parkinson ’ s disease – associated pathological changes in the cerebellum

  2013cites this paper
• Specific frequency band of amplitude low-frequency fluctuation predicts Parkinson's disease.

  2013cites this paper
• Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.

  2013cites this paper
• De ziekte van Parkinson: van geremde motoriek tot ontremde impulsen

  2013cites this paper
• Role of inflammation in depression: implications for phenomenology, pathophysiology and treatment.

  2013cites this paper
• Mesocortical dopaminergic dysfunction in Parkinson's disease-depression: Evidence from a 123I-FP-CIT SPECT investigation

  2013cites this paper
• PET studies in Parkinson's disease dyskinesias and dementia

  2012cites this paper
• Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson’s disease

  2012cites this paper
• Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior

  2012cites this paper
• Functional neuroimaging in Parkinson's disease.

  2012cites this paper
• Depression and Movement Disorders

  2012cites this paper
• Perfusion and metabolism imaging studies in Parkinson's disease.

  2012cites this paper
• Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise.

  2012cites this paper
• The neural substrates of script knowledge deficits as revealed by a PET study in Huntington's disease.

  2011cites this paper
• Emotional Dysfunction in Parkinson’s Disease

  2011cites this paper
• Association of olfactory dysfunction and brain. Metabolism in Parkinson's disease

  2011influential citation
• Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease.

  2011cites this paper
• Imaging biomarkers in Parkinson's disease.

  2011cites this paper
• Parkinson's disease: The quintessential neuropsychiatric disorder

  2011cites this paper
• Illusory misidentifications and cortical hypometabolism in Parkinson's disease

  2011cites this paper
• A failure to communicate: Preliminary evidence for cortico‐striatal dysconnection with pathological gambling in Parkinson's disease

  2011cites this paper
• Functional Imaging in Movement Disorders

  2011cites this paper
• Neuropsychological Functions and SPECT Neuroimaging in Parkinson’s Disease

  2011cites this paper
• Magnetic resonance imaging of cognition in Parkinson’s disease

  2011cites this paper
• PET and MR imaging in Parkinson’s disease patients with cognitive impairment. A study of dopaminergic dysfunction, amyloid deposition, cortical hypometabolism and brain atrophy

  2011cites this paper
• Decision Making under Risk Condition in Patients with Parkinson’s Disease: A Behavioural and fMRI Study

  2010cites this paper
• Imaging, Cognition, and Parkinson's Disease—An Overview

  2010cites this paper
• A mathematical model of inflammation during ischemic stroke

  2010cites this paper
• Neuropsychology of Movement Disorders and Motor Neuron Disease

  2010cites this paper
• Functional Imaging of Cognitive Impairment in Parkinson's Disease

  2010cites this paper
• Neuroimaging and Cognition in Parkinson's Disease Dementia

  2010cites this paper
• GENERAL HOSPITAL WITHOUT CONSULTATION-LIAISON PSYCHIATRIST

  2010cites this paper
• Does the Brain Prefer Geometrical Homogeneity?

  2010cites this paper
• Pathophysiological mechanisms in Parkinson's Disease related dementia: an MEG study.

  2010cites this paper
• Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.

  2009cites this paper
• A Case of Cerebellar Dysfunction After Acute Organotin Poisoning.

  2009cites this paper
• ΠANEΠIΣTHMIO ΠATPΩN ΣXOΛH EΠIΣTHMΩN YΓEIAΣ TMHMA IATPIKHΣ

  2009cites this paper
• HMPAO SPECT in Parkinson’s disease (PD) with major depression (MD) before and after antidepressant treatment

  2009cites this paper
• Do parkinsonian patients have trouble telling lies? The neurobiological basis of deceptive behaviour

  2009cites this paper
• Exploration of beneficial and deleterious effects of inflammation in stroke: dynamics of inflammation cells

  2009cites this paper
• Role of Imaging Techniques in Discerning Neurobehavioral Changes in Ischemic, Neurodegenerative and Demyelinating Disorders

  2009cites this paper
• Exploration of beneficial and deleterious effects of inflammation in stroke: dynamics of inflammation cells

  2009cites this paper
• Neuropsychology of dementia with Lewy bodies.

  2008cites this paper
• Does motor subtype influence neurocognitive performance in Parkinson’s disease without dementia?

  2008cites this paper